Company news
Rockwell Medical, Inc. (NASDAQ:RMTI) news
Rockwell Medical, Inc. news releases on 6ix. Latest, Jan 13, 2021: Rockwell Medical Announces Dosing of First Patient in Pivotal Triferic® Phase 3 Trial…
Press releases — page 3
Rockwell Medical Announces Dosing of First Patient in Pivotal Triferic® Phase 3 Trial by Partner, Wanbang Biopharmaceuticals, in China
January 12, 2021
Industry Veteran Andrea Heslin Smiley joins Rockwell Medical’s Board of Directors
December 15, 2020
Rockwell Medical, Inc. Provides Third Quarter 2020 Financial and Operational Update
November 8, 2020
Rockwell Medical to Report Third Quarter 2020 Financial and Operating Results on November 9, 2020
October 26, 2020
Rockwell Medical, Inc. Announces Presentations at the American Society of Nephrology Virtual Kidney Week 2020
October 12, 2020
Rockwell Medical Announces Growth Plan and New Therapeutic Opportunities for Its Ferric Pyrophosphate Citrate (FPC) Platform
September 23, 2020
Rockwell Medical Announces $35.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
September 22, 2020
Rockwell Medical Announces Appointment of Russell L. Skibsted as Executive Vice President, Chief Financial Officer and Chief Business Officer
September 14, 2020
Rockwell Medical Enters into Exclusive License Agreement with Jeil Pharmaceutical Co., Ltd., for the Rights to Commercialize Triferic® in South Korea
September 8, 2020
Rockwell Medical, Inc. Provides Second Quarter 2020 Financial and Operational Update
August 9, 2020
Rockwell Medical, Inc. Appoints Dr. Allen R. Nissenson to Board of Directors
June 9, 2020
Rockwell Medical, Inc. Files New Drug Submission with Health Canada for Marketing Approval of Triferic® AVNU™
May 25, 2020
Rockwell Medical, Inc. Provides First Quarter 2020 Financial and Operational Update and Top-line Real-World Triferic Data
May 10, 2020
Rockwell Medical, Inc. Appoints Russell H. Ellison, M.D., M.Sc., as President and Chief Executive Officer
April 19, 2020
Rockwell Medical, Inc. Appoints Pharmaceutical Industry Leader Robert S. Radie to Board of Directors
March 30, 2020
Rockwell Medical, Inc. Receives FDA Approval for Triferic® AVNU (Ferric Pyrophosphate Citrate), Intravenous Formulation of Triferic for Replacement of Iron and Maintenance of Hemoglobin in Hemodialysis Patients
March 26, 2020
Rockwell Medical, Inc. Announces $35 Million Debt Financing Agreement with Innovatus Capital Partners, LLC
March 16, 2020
Rockwell Medical, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results
March 11, 2020
Rockwell Medical, Inc. Provides Business Update
February 26, 2020
Rockwell Medical Announces Pricing of $7.5 Million Public Offering of Common Stock
February 3, 2020
Rockwell Medical Announces Proposed Public Offering of Common Stock
February 2, 2020
Rockwell Medical, Inc. Enters into Exclusive License and Supply Agreements with Sun Pharma for the Rights to Commercialize Triferic® in India
January 13, 2020
Rockwell Medical, Inc. Appoints Russell H. Ellison, MD, MSc, to Board of Directors
January 8, 2020
Rockwell Medical, Inc. Expands Medical Capabilities
November 19, 2019
Rockwell Medical, Inc. Reports Third Quarter 2019 Financial Results
November 10, 2019
Rockwell Medical, Inc. Appoints John P. McLaughlin Chairman of the Board of Directors
October 30, 2019